|
Fred Hutchinson Cancer Research Centre Chooses GenoLogics Tuesday, May 20, 2008 GenoLogics, the leading developer of translational research informatics software, today announced that the Fred Hutchinson Cancer Research Center has selected GenoLogics to collaborate with the company to develop an integrated biorepository and biomedical informatics software solution for the Center’s Translational and Outcomes Research group. The GenoLogics software is being provided to Fred Hutchinson Cancer Research Center by the Canary Foundation, a nonprofit, tax exempt public charity committed to the development of early-detection tests for solid-tumor cancers. Read more International Cooperation: Benefits Beyond Boundaries BIOTECH NEWS In today's shrinking world, no country can afford to isolate itself in a knowledge-based economy. Moreover, there are a number of problems in health, agriculture, energy and environment that can be solved only through international partnerships. Indian biotechnology, therefore, while solidly rooted in home soil has to have a global outlook.... Last year's MoU between the National Research Council (NRC), Canada and DBT has led to the signing of an agreement in September 2007 with NRC-Plant Biotechnology Institute at Saskatoon with each party pledging Ca$ 5 million to the R&D partnership in the areas of oilseed genomics and plants for health & wellness. Read more India Calling Delegation The India Calling Delegation to Vancouver on June 18-19, 2008 was extensively covered by Indian media. View Part 1 of the coverage View Part 2 of the coverage View "India Calling Meet in Canada a Hit, Opens Investment Opportunities" View "IMC’s ‘India Calling’ conference in Canada proves to be thumping success" Canada’s bio-economy growing but at risk, study finds June 26, 2008 (Ottawa) – Canada’s biotechnology sector is strong and growing, but immediate skills shortages threaten its sustainability as an important emerging platform of Canada’s economy. A ground-breaking new study released today by BioTalent Canada reveals enormous growth in the sector over the past two decades, with small well-established employers as the backbone. Read more FDA clears OneTouch Ping for wireless glucose management By Amanda Pedersen Medical Device Daily Staff Writer Published July 2, 2008 Yesterday the company reported FDA clearance of the device, which it says is the first full-feature insulin pump that wirelessly communicates with a blood glucose meter-remote. Read more Angiotech to Establish Separate Operating and Royalty Businesses ARES Management and New Leaf Venture Partners Commit to Purchase Convertible Notes in New Subsidiary of $200 to $300 Million Transaction Proceeds to be Used to Reduce Angiotech Debt July 7, 2008 VANCOUVER, BC, July 7, 2008 – Angiotech Pharmaceuticals, Inc. (NASDAQ: ANPI, TSX: ANP), a global specialty pharmaceutical and medical device company, today announced that Angiotech’s Board of Directors has authorized a transaction to create a new subsidiary, Angiotech Pharmaceutical Interventions, Inc. (“API”). Angiotech will contribute to API certain business assets and intellectual property, which include primarily business assets of Angiotech other than the intellectual property and royalty revenue related to the TAXUS® coronary stent system. Read more SFU Builds Asia Pacific Alliances By: Dr. B. Mario Pinto, Vice President, Research Canada’s Asia Pacific Gateway Strategy has expanded beyond strategic investments in transportation infrastructure to include a focus on fostering strong relationships in education, research, and the exchange of innovative ideas and technologies. Asia’s rapid urbanization is presenting new global challenges and opportunities, and by lending our collective knowledge and building our research capacity through partnerships with Asia Pacific institutions, we can play a valuable role in the solution. Read more Human waste proposed as source of natural gas Scott Simpson, Vancouver Sun Published: Tuesday, July 22, 2008 Terasen Gas customers on the North Shore could soon be firing up their furnaces and hot-water heaters with natural gas collected as a byproduct in the processing of human waste. A $1.1-million project involving Terasen, Metro Vancouver and QuestAir Technologies proposes to capture and purify "biogas" from operations at the Lions Gate sewage treatment plant and pump it into a nearby Terasen distribution pipe for use by the gas utility's customers. Read more Download the Feasibility Study |
 Suite 900 - 1188 West Georgia St.
Vancouver, BC V6E 4A2 |